Evidence map›Paper›PMID 41589298›Full record

ArticleClinical medicine insights. Case reports2026

Pan-Resistant

Arihant Surana, Riya Bhattacharya, Houman Javady, Gurman Bhullar, Prajnasini Satapathy, Arun Kumar, Sorabh Lakhanpal, Prakasini Satapathy, Rekha Arcot, Rodrigue Ndabashinze and 1 more

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Clinical medicine insights. Case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Genotype Versus Phenotype in Pandrug-ResistantClinical medicine insights. Case reports · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Arihant SuranaDepartment of Internal Medicine, Saint Vincent Hospital, Worcester, MA, USA.
Riya BhattacharyaDepartment of Internal Medicine, Saint Vincent Hospital, Worcester, MA, USA.
Houman JavadyDepartment of Internal Medicine, Saint Vincent Hospital, Worcester, MA, USA.
Gurman BhullarSri Guru Ram Das University of Health Science and Research, Amritsar, India.
Prajnasini SatapathyCenter for Global Health Research, Saveetha Medical College and Hospital, Saveetha Institute of Medical and Technical Sciences, Saveetha University, Chennai, India.
Arun KumarFaculty of Pharmaceutical Sciences, Graphic Era Hill University, Dehradun, India.
Sorabh LakhanpalSchool of Pharmaceutical Sciences, Lovely Professional University, Phagwara, India.
Prakasini SatapathyUniversity Center for Research and Development, Chandigarh University, Mohali, India.
Rekha ArcotDr. D. Y. Patil Medical College Hospital and Research Centre, Dr. D. Y. Patil Vidyapeeth (Deemed-to-be-University), Pimpri, Pune, India.
Rodrigue NdabashinzeUniversity of Burundi, Bujumbura, Burundi.ORCID https://orcid.org/0009-0001-6921-7828
Amogh VermaDepartment of Internal Medicine, Rama Medical College Hospital and Research Center, Hapur, India.ORCID https://orcid.org/0000-0003-2499-4874

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Case Presentation: We describe a 66-year-old man with chronic hypoxic respiratory failure, chronic kidney disease, and recurrent infections who was admitted with septic shock. Initial broad-spectrum antibiotics were ineffective, and cultures yielded PDR Discussion: This case illustrates the therapeutic futility posed by pan-drug-resistant (PDR) Conclusion: PDR

Indexed as

bacteriophage therapycefiderocol resistanceemerging antimicrobial therapiesextensively drug-resistant Pseudomonas aeruginosa (XDR-PA)pan-drug resistant Pseudomonas aeruginosa (PDR-PA)refractory septic shock

Identifiers

PMID41589298
PMCPMC12831877

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.